Phase 1/2 clinical trial builds on encouraging pilot study
Post-processing and machine learning techniques add abundant value
Exploring rates, drivers and implications of failed catheter removal
Resourcefulness is the rule to customize solutions for patient progress
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Largest study to date underscores mental status, etiology, epileptiform patterns
Drug stimulates an immune response to survivin
Individual tumor DNA may be key
A closer look at AD drug therapies
Established lymphoma/leukemia therapy also targets glioma stem cells
Cleveland Clinic researchers make the case for investigative urgency
Advertisement
Advertisement